Marshall Wace’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-581,573
Closed -$59.1M 3343
2025
Q4
$59.1M Buy
581,573
+11,936
+2% +$959K 0.05% 306
2025
Q3
$31.2M Buy
569,637
+139,918
+33% +$6.99M 0.03% 480
2025
Q2
$22.8M Buy
429,719
+403,724
+1,553% +$20.5M 0.03% 539
2025
Q1
$1.13M Sell
25,995
-75,178
-74% -$3.81M ﹤0.01% 1732
2024
Q4
$5.68M Buy
+101,173
New +$6.3M 0.01% 1004
2023
Q3
Sell
-975,054
Closed -$91.6M 2334
2023
Q2
$91.6M Buy
+975,054
New +$76.1M 0.18% 115
2022
Q4
Sell
-33,823
Closed -$1.1M 3077
2022
Q3
$1.1M Buy
33,823
+27,621
+445% +$1.14M ﹤0.01% 2362
2022
Q2
$245K Buy
+6,202
New +$332K ﹤0.01% 3095
2022
Q1
Sell
-4,007
Closed -$312K 3529
2021
Q4
$312K Sell
4,007
-114,413
-97% -$10.1M ﹤0.01% 3019
2021
Q3
$11.3M Buy
118,420
+116,684
+6,721% +$12.3M 0.05% 488
2021
Q2
$216K Sell
1,736
-25,014
-94% -$2.99M ﹤0.01% 2424
2021
Q1
$3.52M Sell
26,750
-138,651
-84% -$19M 0.02% 1028
2020
Q4
$21.9M Buy
+165,401
New +$20M 0.12% 174
2020
Q2
Sell
-46,963
Closed -$2.72M 1660
2020
Q1
$2.72M Buy
46,963
+19,140
+69% +$1.55M 0.03% 533
2019
Q4
$2.57M Buy
+27,823
New +$2.45M 0.02% 732
2019
Q1
Sell
-6,964
Closed -$439K 1817
2018
Q4
$439K Buy
+6,964
New +$478K ﹤0.01% 1155
2017
Q1
Sell
-97,867
Closed -$1.31M 439
2016
Q4
$1.31M Buy
+97,867
New +$1.58M 0.01% 725
2015
Q4
Sell
-81,900
Closed -$1.47M 1013
2015
Q3
$1.47M Buy
+81,900
New +$1.88M 0.02% 532
2014
Q2
Sell
-19,433
Closed -$275K 966
2014
Q1
$275K Buy
+19,433
New +$262K 0.01% 711

Other funds holding EXAS

Marshall Wace's EXAS Position: Q1 2026 in Review

Marshall Wace sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 581,573 shares — an estimated $59.1M sold.

Marshall Wace first reported a position in EXAS in Q1 2014 and held it in 19 quarters. The position peaked at $91.6M in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Marshall Wace reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Marshall Wace sold 581,573 Exact Sciences shares in Q1 2026, an estimated $59.1M.
  • Marshall Wace first reported a position in Exact Sciences in Q1 2014 and held it in 19 quarters.
  • Marshall Wace's Exact Sciences position peaked at $91.6M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.